Unease Over Seconded Philanthropic Foundation Staff To Top Management At WHO 15/12/2015 by Intellectual Property Watch, Intellectual Property Watch 1 Comment Third World Network reports: Philanthropic foundations such as the Bill & Melinda Gates Foundation and the United Nations Foundation have seconded their staffers to top management positions at the World Health Organization.
New Standard For Online Linking Of Rights Data Emerges, But Will It Take Off? 15/12/2015 by Dugie Standeford for Intellectual Property Watch Leave a Comment A new standard developed and tested by the Linked Content Coalition’s Rights Data Integration project could revolutionise the way copyrights are managed online, one of its technical advisors has said in an interview. The question now is whether organisations are willing to use and pay for it.
Artists’ Call For Rights Wakes Up WIPO Copyright Committee 14/12/2015 by Catherine Saez, Intellectual Property Watch 1 Comment Two new proposals concerning the rights of artists seemed to bring new energy to the World Intellectual Property Organization copyright committee last week. Proposals encouraged delegates to create a legal framework to help artists benefit from use of their works and royalties by intermediaries.
European Commission Unveils First Copyright Reform Proposals To Mixed Review 09/12/2015 by Dugie Standeford for Intellectual Property Watch 1 Comment The European Commission’s long-awaited effort to reform Europe’s copyright system includes a proposal for cross-border portability of online content services and an action plan for updating copyright rules. The proposals are the first in its Digital Single Market strategy, the EC said. The announcement prompted mixed reviews from internet service provider and consumer groups and one EU lawmaker but a warmer reception from rights holders.
Authors: Fair Dealing In Copyright Law If Ill-Defined Is Prejudicial To Writers 08/12/2015 by Catherine Saez, Intellectual Property Watch 1 Comment On the side of this week’s World Intellectual Property Organization Standing Committee on Copyright and Related Rights (SCCR), the International Authors Forum held a side event on 7 December. Speakers underlined the importance of copyright for authors so that they can make a living from their writing, and warned about ill-defined fair use in copyright law.
Report: Ebola Distracted Global R&D Funding For Neglected Diseases; Public Funding At Low 08/12/2015 by Catherine Saez, Intellectual Property Watch 1 Comment A newly issued report provides the “first ever” picture of global investment in Ebola research and development. The report found that investment in Ebola might have come at the expense of other funding to develop drugs, vaccines and diagnostics for other neglected diseases. The report also found that public funding on research and development for neglected diseases was at its lowest in years.
The Anniversary The World Trade Organization Would Rather Forget 06/12/2015 by Peter Ungphakorn for Intellectual Property Watch 3 Comments The World Trade Organization (WTO)’s 20th anniversary celebrations are about to reach a climax with the 15–18 December Nairobi Ministerial Conference — the first to be held in Africa — following a celebratory Public Forum in Geneva in October. Just over a week before Nairobi, another anniversary is slipping by almost unnoticed. Today, December 6, is the 10th anniversary of a decision that the Director-General at the time, Pascal Lamy, hailed as confirmation “once again that members are determined to ensure the WTO’s trading system contributes to humanitarian and development goals.”
Law Boosts Awareness, Patents From Research Institutions In South Africa 04/12/2015 by Munyaradzi Makoni for Intellectual Property Watch Leave a Comment CAPE TOWN, South Africa — A law to regulate intellectual property derived from research and development conducted using public funds has boosted the number of patent applications filed and granted by universities and research institutions in the past five years.
Colombia Asked To Declare Excessive Price For Cancer Drug Contrary To Public Interest, Grounds For Compulsory License 03/12/2015 by Intellectual Property Watch 11 Comments Colombia has a decision to make. A full year has passed from the November 24, 2014 request by iFarma, Misión Salud and CIMUN for a declaration of the public interest regarding the cancer drug imatinib (marketed by Novartis as Gleevec/Glivec), the first step on the path toward a compulsory license in Colombia. Thus far, Colombia’s Ministry of Health and Social Protection has failed to act one way or another, leaving patients in limbo and the government at the mercy of a Swiss pharmaceutical giant that reported revenue of over $57.9 Billion USD in 2013, write James Love and Andrew S. Goldman.
US Congressional Study Finds Excessive Profit-Seeking In USD84K Hepatitis Drug Sovaldi 01/12/2015 by Intellectual Property Watch Leave a Comment Two bipartisan United States senators today released the results of an 18-month investigation into the US$84,000 price of the Sovaldi hepatitis C drug, finding the pricing and marketing strategy was aimed at maximizing revenue at the expense of access and affordability. The new report also shows the high impact on US government drug procurement programs and other data.